Approval · Notice of Compliance 13358 · 2012
YAZ PLUS: Notice of Compliance 13358
Issued June 6, 2012
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 13358
- Date
- June 6, 2012
- Company
- Bayer Inc.Elkhart, Indiana, United States
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Other
- Therapeutic class
- Oral Contraceptive
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| YAZ PLUS | 02387433 | Marketed |
Medicinal ingredients
- LEVOMEFOLATE CALCIUM 0.451 MG per TAB
- ETHINYL ESTRADIOL 0.02 MG per TAB
- DROSPIRENONE 3 MG per TAB